NCT03110770: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03110770 |
|---|---|
| Title | VRC 705: A Phase 2/2B, Randomized Trial to Evaluate the Safety, Immunogenicity and Efficacy of a Zika Virus DNA Vaccine in Healthy Adults and Adolescents |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 29, 2017 |
| Completion date | Oct. 4, 2019 |
| Required reporting date | Oct. 3, 2020, midnight |
| Actual reporting date | Oct. 2, 2020 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |